Akston Biosciences Corporation (AXTN)

Akston Biosciences will go public soon, but the exact IPO date is still unknown.

IPO Price Range

$8.00 - $10.00

Shares Offered

2,222,222

Deal Size

$20.00M

Akston Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Year Ending	Current	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Market Capitalization	61	-	-
Market Cap Growth	-	-	-
Enterprise Value	69	-	-

Financial Efficiency

Year Ending	Current	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Debt / Equity Ratio	-0.84	-2.40	-0.58
Debt / EBITDA Ratio	2.19	1.40	-
Net Debt / Equity Ratio	-0.61	-1.99	-0.51
Net Debt / EBITDA Ratio	1.60	1.16	-
Quick Ratio	0.70	0.63	0.07
Interest Coverage	1.86	2.78	-
Return on Assets (ROA)	-	36.72%	-72.11%
Return on Invested Capital (ROIC)	-	-496.78%	-
Return on Capital Employed (ROCE)	-77.98%	89.98%	986.05%